Boston Judge Dismisses Thermo Finnigan Claim Against Bruker | GenomeWeb

NEW YORK, April 23 – Mass spectrometer developer Bruker Daltonics said Monday that the United States District Court of the District of Massachusetts has allowed its summary judgment motion of non-infringement of a Thermo Finnigan patent.

Thermo Finnigan had previously sued Bruker for infringing on its patent for its ion trap mass spectrometry, and more specifically on its mass selective instability scan. Bruker argued that its esquire ion trap mass spectrometers uses a non-linear resonance ejection scan for unsurpassed resolution, speed and sensitivity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.